Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Tumor Immunotherapy01:27

Tumor Immunotherapy

520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Nursing Clinical Information System01:27

Nursing Clinical Information System

769
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
769
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

2.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Enhanced Method for Transmitochondrial Cybrid Generation.

Cells·2026
Same author

What is the evidence for physical interventions for people living with advanced dementia in the community? A meta-review.

BMJ supportive & palliative care·2026
Same author

Stroke rehabilitation in adults: summary of updated NICE guidance.

BMJ (Clinical research ed.)·2024
Same author

Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trial.

The lancet. Healthy longevity·2024
Same author

Acceptability of a behavioural intervention to mitigate the psychological impacts of COVID-19 restrictions in older people with long-term conditions: a qualitative study.

BMJ open·2023
Same author

See and Eat! The impact of repeated exposure to vegetable ebooks on young children's vegetable acceptance.

Appetite·2023

Related Experiment Video

Updated: Jun 27, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K

Development of an implementation science informed "Test Evidence Transition" program to improve cancer outcomes.

Kate E Hamilton-West1, Alexandra Feast1, Natalie A Masento1

  • 1Social and Behavioral Research Team, Evidence and Implementation Department, Policy Information and Communications Directorate, Cancer Research UK, London, United Kingdom.

Frontiers in Health Services
|May 3, 2024
PubMed
Summary

The Test Evidence Transition (TET) program accelerates cancer research into practice by funding and supporting health systems to implement and evaluate innovations. This initiative aims to bridge the gap between evidence and equitable adoption, improving cancer outcomes.

Keywords:
behavioral sciencecancerevaluationimplementation researchimplementation sciencequality improvement

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K

Related Experiment Videos

Last Updated: Jun 27, 2025

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K

Area of Science:

  • Implementation Science
  • Health Services Research
  • Cancer Care Delivery

Background:

  • Translating cancer research into clinical practice typically takes approximately 15 years.
  • Implementation science offers methods and frameworks to address the gap between research findings and real-world application.
  • Improving cancer outcomes requires effective strategies to bridge this implementation gap.

Purpose of the Study:

  • To describe the development of the Test Evidence Transition (TET) program.
  • To outline the program's objectives: testing innovations, evidencing implementation, and ensuring transition of best practices.
  • To facilitate the adoption of evidence-based cancer care pathways across UK health systems.

Main Methods:

  • The TET program provides funding and support to health system delivery teams and project partners.
  • Phase 1 (launched April 2023) involved identifying motivated teams and supporting proposal development with academic input.
  • Peer-reviewed proposals were selected for funding to implement and evaluate pathway innovations.

Main Results:

  • Phase 1 focused on pathway innovations for breast and prostate cancer diagnosis.
  • The program successfully engaged academic and health system partners in innovation implementation and evaluation.
  • The TET program is now launching Phase 2, expanding its focus to colorectal cancer.

Conclusions:

  • The TET program aims to improve cancer outcomes by addressing local barriers to evidence-based practice.
  • It seeks to translate research findings into consistent and equitable adoption across diverse health systems.
  • The program's phased approach allows for iterative learning and expansion to new cancer types.